Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 181,496 $ 130,572
Short-term restricted cash 971 105
Short-term investments 18,587 0
Accounts receivable, net 178,072 119,724
Inventory 165,970 131,703
Prepaid expenses and other current assets 17,879 22,000
Total current assets 562,975 404,104
Long-term restricted cash 26 1,061
Property and equipment, net 67,081 60,924
Leased right-of-use assets 30,041 27,269
Intangible assets, net 122,142 152,540
Goodwill 306,739 306,668
Deferred tax assets 65,767 89,168
Other long-term assets 27,927 8,650
Total assets 1,182,698 1,050,384
Current liabilities:    
Accounts payable 90,845 52,976
Accrued price protection liability 116,591 40,509
Accrued expenses and other current liabilities 94,414 57,268
Accrued compensation 49,468 56,642
Total current liabilities 351,318 207,395
Long-term lease liabilities 25,040 24,640
Long-term debt 171,607 306,153
Other long-term liabilities 18,852 22,998
Total liabilities 566,817 561,186
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 78,565 shares issued and outstanding at September 30, 2022 and 76,778 shares issued and outstanding December 31, 2021 8 8
Additional paid-in capital 697,649 657,485
Accumulated other comprehensive income (loss) (5,316) 2,125
Accumulated deficit (76,460) (170,420)
Total stockholders’ equity 615,881 489,198
Total liabilities and stockholders’ equity $ 1,182,698 $ 1,050,384